Article metrics

Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease

 

Online download statistics by month:

Online download statistics by month: to

AbstractFullPdf
Total000